SCHEMBL7327200

SCHEMBL7327200

Cc1ccccc1CN(C[C@@H](O)CCc1ccccc1)N(NC(=O)OCc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 6/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SYK P43405 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
AKT1 P31749 2/20 0.39
KCNA5 P22460 1/20 0.38
LMNA P02545 2/20 0.38
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
SLC1A5 Q15758 1/20 0.37
MAPT P10636 1/20 0.36
CTSL P07711 1/20 0.36
JAK2 O60674 1/20 0.36
S1PR4 O95977 1/20 0.36
HSP90AA1 P07900 1/20 0.36
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7332905 0.90 LMNA (0.46) BACE1SMN1; SMN2SYKAKT1LMNA
SCHEMBL8333233 0.89 BACE1 (0.44) BACE1SMN1; SMN2SYKAKT1LMNA
SCHEMBL8333205 0.88 SMN1; SMN2 (0.44) BACE1SMN1; SMN2SYKAKT1LMNA
SCHEMBL7328253 0.87 BACE1 (0.47) BACE1SMN1; SMN2MEN1KMT2ASYK
SCHEMBL7366418 0.86 BACE1 (0.44) BACE1SMN1; SMN2MEN1KMT2ASYK
SCHEMBL7331893 0.86 BACE1 (0.44) BACE1SMN1; SMN2MEN1KMT2ASYK
SCHEMBL8333717 0.85 BACE1 (0.40) BACE1SMN1; SMN2MEN1KMT2ASYK
SCHEMBL7328963 0.85 BACE1 (0.44) BACE1SMN1; SMN2MEN1KMT2ASYK
SCHEMBL8331022 0.85 BACE1 (0.43) BACE1SMN1; SMN2SYKAKT1LMNA
SCHEMBL8469355 0.85 CYP3A4 (0.45) BACE1SMN1; SMN2ALDH1A1SYKSLC1A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5990135-A FOR TREATING A RETROVIRAL INFECTION SUCH AS HIV INFECTION; FOR EXAMPLE 5S-N-((2-PYRIDINYL)METHOXYCARBONYL)VALINYLAMINO-2-((N-3 -PYRIDINYL)METHOXYCARBONYL)AMINO-4S-HYDROXY-1,6-DIPHENYL-2-AZAHEXANE AND OTHER COMPOUNDS OF GIVEN FORMULA ABBOTT LABORATORIES (US) 1999-11-23 US disclosed
US-5631376-A PEPTIDE DERIVATIVES FOR TREATMENT OF AIDS ABBOTT LABORATORIES (US) 1997-05-20 US disclosed
US-5621109-A OXAZOLE/THIAZOLE DERIVATIVES OF HYDROXYMETHYL HYDRAZONES; SIDE EFFECT REDUCTION ABBOTT LABORATORIES (US) 1997-04-15 US disclosed
US-5461067-A For HIV infections ABBOTT LABORATORIES (US) 1995-10-24 US disclosed
WO-1994019332-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1994-09-01 WO disclosed